Details About Generic Salt ::  Cyprohep

Main Medicine Class::    

(sip-row-HEP-tuh-deen HIGH-droe-KLOR-ide)

Periactin

Tablets

4 mg

Syrup

2 mg/5 mL

PMS-Cyproheptadine

Class: Antihistamine

Drugs Class ::

 Action Competitively antagonizes histamine at H₁ receptor sites. Also exhibits antiserotonin activity.

Indications for Drugs ::

 Indications Symptomatic relief of perennial and seasonal allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis; amelioration of allergic reactions to blood or plasma; management of allergic pruritic symptoms, mild skin manifestations of uncomplicated urticaria and angioedema, and cold urticaria.

Drug Dose ::

 Route/Dosage

Adults: PO 4 mg q 8 hr then 4 to 20 mg/day; not to exceed 0.5 mg/kg/day.

Children: PO Total daily dosage 0.25 mg/kg or 8 mg/m².

Children 7 to 14 yr: PO 4 mg bid or tid (max, 16 mg/day).

Children 2 to 6 yr: PO 2 mg bid or tid (max, 12 mg/day).

Contraindication ::

 Contraindications Hypersensitivity to antihistamines; newborn or premature infants; nursing mothers; narrow-angle glaucoma; stenosing peptic ulcer; symptomatic prostatic hypertrophy; asthmatic attack; bladder neck obstruction; pyloroduodenal obstruction; MAO therapy.

Drug Precautions ::

 Precautions

Pregnancy: Category B. Lactation: Contraindicated in nursing women. Children: Safety and efficacy in children younger than 2 yr not established. Elderly: Dosage reduction may be required. Special risk patients: Use drug with caution in patients with predisposition to urinary retention, history of bronchial asthma, increased intraocular pressure, hyperthyroidism, cardiovascular disease, or hypertension. Hepatic impairment: Use drug with caution in patients with cirrhosis or other liver disease. Respiratory disease: Generally not recommended for treatment of lower respiratory tract symptoms including asthma. Sedatives/CNS depressants: Avoid in patients with history of sleep apnea.

Drug Side Effects ::

 Adverse Reactions

CARDIOVASCULAR: Orthostatic hypotension; palpitations; tachycardia; reflex tachycardia; extrasystoles; faintness. CNS: Drowsiness (often transient); sedation; dizziness; faintness; disturbed coordination; confusion; restlessness; excitement; nervous tremor; paresthesias; convulsions; hallucinations. DERMATOLOGIC: Photosensitivity; rash. EENT: Dry mouth, nose, and throat; sore throat. GI: Epigastric distress; nausea; vomiting; diarrhea; anorexia; constipation; change in bowel habits. HEMATOLOGIC: Hemolytic anemia; thrombocytopenia; agranulocytosis. HEPATIC: Jaundice. RESPIRATORY: Thickening of bronchial secretions; chest tightness; wheezing; nasal stuffiness; respiratory depression.

Drug Mode of Action ::  

 Action Competitively antagonizes histamine at H₁ receptor sites. Also exhibits antiserotonin activity.

Drug Interactions ::

 Interactions

Alcohol, CNS depressants: May cause additive CNS depressant effects.

Fluoxetine: Effects of fluoxetine may be reversed.

MAOIs: Anticholinergic effects of cyproheptadine may increase.

Drug Assesment ::

 Assessment/Interventions

• Obtain patient history, including drug history and any known allergies.
• Assess baseline vital signs and lung sounds.
• For diabetic patients, monitor blood glucose closely if taking sugar-based syrups.
• Monitor weight weekly for significant increases.
• Perform regular assessments and notify health care provider if patient exhibits signs of cardiovascular, neurologic, or respiratory dysfunction (eg, cardiac arrhythmia, hypotension, increased drowsiness or agitation, confusion, chest tightness, wheezing).

Drug Storage/Management ::

 Administration/Storage

• Administer medication with meals.
• Scored tablets may be crushed.
• Store in tightly closed container at room temperature.

Drug Notes ::

 Patient/Family Education

• Instruct diabetic patients to monitor blood glucose closely if taking syrup preparations.
• Alert patients that syrup preparations contain alcohol, and advise against taking any additional alcoholic beverages or CNS depressants throughout therapy.
• Explain potential effects of chronic dryness of oral tissues and encourage patient to maintain good oral hygiene and obtain regular dental care.
• Explain that skin testing procedures may be affected if drug is not discontinued at least 4 days prior to test.
• Tell patient to report any adverse reactions, including changes in urinary habits, to health care provider.
• Instruct patient to take sips of water frequently, suck on ice chips or sugarless hard candy, or chew sugarless gum if dry mouth occurs.
• Advise patient that drug may cause drowsiness and to use caution while driving or performing other tasks requiring mental alertness.
• Caution patients to avoid exposure to sunlight and prolonged exposure to extreme heat and to use sunscreen or wear protective clothing to avoid photosensitivity reaction.
• Instruct patient not to take OTC medications without consulting health care provider.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.